The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Abstract
Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases represent major sources of this reactive oxygen species and have been found upregulated and activated in animal models of hypertension, diabetes, and sedentary lifestyle and in patients with cardiovascular risk factors. Superoxide (O 2 · − ) reacts avidly with vascular NO· to form peroxynitrite (ONOO − ). The cofactor BH 4 is highly sensitive to oxidation by ONOO − . Diminished levels of BH 4 promote O 2 · − production by eNOS (referred to as eNOS uncoupling). This transformation of eNOS from a protective enzyme to a contributor to oxidative stress has been observed in several in vitro models, in animal models of cardiovascular diseases, and in patients with cardiovascular risk factors. In many cases, supplementation with BH 4 has been shown to correct eNOS dysfunction in animal models and patients. In addition, folic acid and infusions of vitamin C are able to restore eNOS functionality, most probably by enhancing BH 4 levels as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling causes eNOS activity to change from healthy (producing NO) to toxic (generating superoxide) (303).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [303]
In the citing paper
“Similarly, vascular disease, cardiovascular disease (CVD), and metabolic syndrome all share effective loss of NO function[23,35–39].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [23]
Citations
Cites
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,466
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,190
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,110
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Research works printed but not linked: 23
- 10.1161/res.86.3.347 · DOI
- Li H Witte K August M Brausch I Gödtel-Armbrust U Habermeier A Closs EI Oelze M Münzel T Förstermann U. Reversal of eNOS uncoupling and upregulation of eNOS expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. In press.
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/circ.100.21.2131 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/hyp.33.6.1353 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/res.86.2.e36 · DOI
- 10.1161/circ.104.10.1119 · DOI
- 10.1161/res.87.2.99 · DOI
- 10.1161/res.87.7.566 · DOI
- 10.1161/hyp.38.5.1044 · DOI
- 10.1161/circ.104.22.2673 · DOI
- 10.1161/circ.94.1.6 · DOI
- 10.1161/circ.97.3.237 · DOI
- 10.1161/atvb.22.1.6 · DOI
- 10.1161/atvb.20.1.185 · DOI
Cited by
Sorted by citations
Items 501–600 of 1,003
Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation
Rodrigo, R., Vinay, J. I., Castillo, R. L., Cereceda, M., René Asenjo, G., Zamorano, J., Julia Araya, A., Castillo-Koch, R., Espinoza, J., & Larraín, E. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.04.043 · Cited by 54
“Hence theOEgrows throughapositive feedback mechanism [31,38,43].”
Yao, Y., Yin, H. H., Shen, B., Chao, L., & Chao, J. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.11.020 · Cited by 54
Sasaki, N., Yamashita, T., Takaya, T., Shinohara, M., Shiraki, R., Takeda, M., Emoto, N., Fukatsu, A., Hayashi, T., Ikemoto, K., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.160754 · Cited by 56
Molina‐Jijón, E., Rodríguez‐Muñoz, R., Namorado, M. C., Bautista-García, P., Medina‐Campos, O. N., Pedraza‐Chaverrí, J., & Reyes, J. L. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.018 · Cited by 54
“Although total eNOS is increased, the dimers of eNOS (the catalytically active form [38]) are decreased under diabetic conditions, which is consistent with the finding that diabetes decreased urinary excretion of NO2 andNO3 (used asmarkers of NO synthesis) and atRA improved NO levels (Fig.”
ResultZemse, S. M., Chiao, C. W., Hilgers, R. H. P., & Webb, R. C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00763.2009 · Cited by 54
Ganz, T., Wainstein, J., Gilad, S., Limor, R., Boaz, M., & Stern, N. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2836 · Cited by 54
Roles for endothelial zinc homeostasis in vascular physiology and coronary artery disease
Zalewski, P. D., Beltrame, J. F., Wawer, A. A., Abdo, A. I., & Murgia, C. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1495614 · Cited by 54
“However, the Zn in eNOS is unusual in that it is ligated to redox-sensitive cysteine thiol clusters on the surface of the monomers (Forstermann and Munzel, 2006).”
BackgroundEffect of fenugreek consumption on serum lipid profile: A systematic review and meta‐analysis
Heshmat‐Ghahdarijani, K., Mashayekhiasl, N., Amerizadeh, A., Teimouri-Jervekani, Z., & Sadeghi, M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6690 · Cited by 54
“ROS and NO can increase the oxidative burden of LDL and may accelerate the atherosclerotic process and plaque rupture (Forstermann & Munzel, 2006; Godo & Shimokawa, 2017).”
BackgroundWang, H., Sun, X., Lü, Q., Zemskov, E. A., Yegambaram, M., Wu, X., Wang, T., Tang, H., & Black, S. M. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101878 · Cited by 56
Arlt, S., Schulze, F., Eichenlaub, M., Maas, R., Lehmbeck, J. T., Schwedhelm, E., Jahn, H., & Böger, R. H. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000144026 · Cited by 53
“Nitric oxide (NO) is a key regulator in the cardiovascular, immune, and neuronal systems. It has been shown that NO is not only involved in the regulation of endothelial function but also in learning and cognitive function [ ,”
BackgroundRakshit, S., Subramanian, B. C., Saha, B., Victor, E. S., Majumdar, S., & Nandi, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.014 · Cited by 51
Haddad, P., Dussault, S., Groleau, J., Turgeon, J., Maingrette, F., & Rivard, A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.038 · Cited by 53
Moien‐Afshari, F., Ghosh, S., Elmi, S., Khazaei, M., Rahman, M. M., Sallam, N. A., & Laher, I. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00016.2008 · Cited by 53
“Although eNOS is present, it is possible that the activity and/or regulation of this enzyme may be negatively altered in DM (16).”
BackgroundInteraction of hyperlipidemia and reactive oxygen species: Insights from the lipid-raft platform
Amiya, E. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i12.689 · Cited by 57
Ran, Q., Wang, J., Wang, L., Zeng, H., Yang, X., & Huang, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00805 · Cited by 53
“Diabetic Vascular Dysfunction Endothelial dysfunction, as characterized by impaired endothelium-dependent vasodilation and reduced bioavailability of nitric oxide (NO), is closely related to T2DM (Huang, 2003; Félétou and Vanhoutte, 2006; Forstermann and Munzel, 2006).”
Steven, S., Frenis, K., Kalinovic, S., Kvandová, M., Oelze, M. W., Helmstädter, J., Hahad, O., Filippou, K. V., Kuś, K., Trevisan, C., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101515 · Cited by 53
“[41]) have been identified as significant superoxide sources contributing to the pro-oxidant state induced by cardiovascular risk factors.”
BackgroundRole of Reactive Oxygen Species in Hyperadrenergic Hypertension
Gayen, J. R., Zhang, K., RamachandraRao, S., Mahata, M., Chen, Y., Kim, H., Naviaux, R. K., Sharma, K., Mahata, S. K., & O’Connor, D. T. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.924050 · Cited by 52
Sabri, M., Ai, J., Marsden, P. A., & Macdonald, R. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017062 · Cited by 52
“Under physiological conditions endothelium-derived NO inhibits thrombosis and platelet adhesion and aggregation, endothelial cell apoptosis, smooth muscle hypertrophy and leucocyte adhesion to the endothelium [4].”
BackgroundInfluentialLobato, N. S., Filgueira, F. P., Akamine, E. H., Davel, A. P., Rossoni, L. V., Tostes, R. C., de Carvalho, M. H. C., & Fortes, Z. B. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.006 · Cited by 53
Kövamees, O., Shemyakin, A. S., & Pernow, J. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116643916 · Cited by 52
Akolkar, G., Bagchi, A. K., Ayyappan, P., Jassal, D. S., & Singal, P. K. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2016 · Cited by 52
“Despite iNOS being a more potent source of NO and O2 than eNOS, uncoupling of eNOS is implicated in many pathological conditions as a result of its inability to produce physiological levels of eNOS-derived NO required for cardiovascular functions (14).”
BackgroundOral melatonin reduces blood coagulation activity: a placebo‐controlled study in healthy young men
Wirtz, P. H., Spillmann, M., Bärtschi, C., Ehlert, U., & von Känel, R. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00499.x · Cited by 53
“Oxidative stress, chronic systemic inflammation and coagulation activation are cornerstone mechanisms in the initiation and progression of atherothrombotic disease such as coronary artery disease (CAD) complicated by acute coronary syndromes [2-4].”
BackgroundWang, J., Chen, L., Fu, L., Chen, M., & Wong, M. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0409-8 · Cited by 52
“Endothelium-derived nitric oxide (EDNO) contributes to regulate vascular tone and maintain peripheral circulatory homeostasis (Cockcroft 2005; Forstermann and Munzel 2006 ).”
BackgroundMaas, R., Schwedhelm, E., Kahl, L., Li, H., Benndorf, R. A., Lüneburg, N., Förstermann, U., & Böger, R. H. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.093575 · Cited by 52
“Major factors that may alter NO signaling in vivo are a reduced substrate availability (9), presence of endogenous NOS inhibitors (10), alterations in NOS expression (11) or localization (12), oxidative stress leading to uncoupling of NOS, and scavenging of NO by free radicals (13).”
BackgroundKim, H., Yun, J., & Kwon, S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2483163 · Cited by 54
“Decreased NO levels are not sufficient to relax SMCs, and this impaired relaxation of blood vessels is closely associated with hypertension [94].”
BackgroundGodos, J., Romano, G. L., Gozzo, L., Laudani, S., Paladino, N., Azpíroz, I. D., López, N. M. M., Giampieri, F., Quiles, J. L., Battino, M. A., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1368949 · Cited by 58
“The activation of SIRT1 induces an upregulation of GTP cyclohydrolase 1 (GCH1) increasing the biosynthesis of tetrahydrobiopterin (BH4) (Li et al., 2019) which is a eNOS cofactor that prevents eNOS uncoupling (Förstermann and Münzel, 2006; Li and Förstermann, 2013; Förstermann et al., 2017).”
BackgroundVascular endothelial cell injury: causes, molecular mechanisms, and treatments
Xia, T., Yu, J., Du, M., Chen, X., Wang, C., & Li, R. (2025) · MedComm · doi:10.1002/mco2.70057 · Cited by 53
Gutkowska, J., Broderick, T. L., Danalache, B. A., Wang, D., Lavoie, J.-M., & Jankowski, M. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.176461 · Cited by 51
“This is in agreement with the lower expression of NOS in db/db mice and indicates that endothelial dysfunction is involved in cardiovascular complications of diabetes (Forstermann & Munzel, 2006).”
ResultBiomarkers of vasospasm development and outcome in aneurysmal subarachnoid hemorrhage
Rodríguez-Rodríguez, A., Egea-Guerrero, J. J., de Azúa-López, Z. R., & Murillo-Cabezas, F. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.04.020 · Cited by 50
Spigoni, V., Mena, P. R., Cito, M., Fantuzzi, F., Bonadonna, R. C., Brighenti, F., Dei, A., & Rio, D. D. (2016) · Molecules · doi:10.3390/molecules21081009 · Cited by 51
Sandrim, V. C., Montenegro, M. F., Palei, A. C., Metzger, I. F., Sertorio, J. T. C., Cavalli, R. D. C., & Tanus-Santos, J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.012 · Cited by 51
“Indeed, NO is a critical regulator of vascular homeostasis [1,2], and it maintains the basal vasodilator tone, inhibits platelet aggregation and leukocytes adhesion, and exerts antioxidant and anti-inflammatory effects [3].”
BackgroundKline, E. R., Kleinhenz, D. J., Liang, B., Dikalov, S., Guidot, D. M., Hart, C. M., Jones, D. P., & Sutliff, R. L. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91447.2007 · Cited by 51
“Although the lack of an effect on BH4 suggests that eNOS is likely not uncoupled in the HIV-1 transgenic rats, it is possible that decreased L-arginine or increased asymmetric dimethylarginine (ADMA) could lead to eNOS uncoupling (34).”
BackgroundHuang, S., Chen, G., Sun, J. M., Chen, Y., Wang, N., Dong, Y., Shen, E., Hu, Z., Gong, W., Jin, L., et al. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00681-z · Cited by 50
“A major defense against vascular injury is endothelial nitric oxide synthase (eNOS), which generates nitric oxide (NO) in the presence of optimal concentrations of the substrate L-arginine and the cofactor (6R)-5,6,7,8tetrahydrobiopterin [15, 16].”
BackgroundInhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
Signori, D., Magliocca, A., Hayashida, K., Graw, J. A., Malhotra, R. K., Bellani, G., Berra, L. M., & Rezoagli, E. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00455-6 · Cited by 54
Tan, Y., Cheong, M. S., & Cheang, W. S. (2022) · Oxygen · doi:10.3390/oxygen2030018 · Cited by 54
“In addition, adding LDLs or oxidated LDLs (oxLDLs) leads to the decrease of the eNOS cofactor tetrahydrobiopterin (BH4) by BH4 oxidation to form 7,8-dihydrobiopterin (BH2) and results in increased ROS production [67].”
BackgroundAdekola, H., Romero, R. J., Chaemsaithong, P., Korzeniewski, S. J., Dong, Z., Yeo, L., Hassan, S. S., & Chaiworapongsa, T. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.964676 · Cited by 50
“This gas diffuses to the vascular smooth muscle cells and activates guanylate cyclase, which leads to cGMP-mediated vasodilatation [106,107,117].”
BackgroundNamikoshi, T., Tomita, N., Satoh, M., Sakuta, T., Kuwabara, A., Kobayashi, S., Higuchi, Y., Nishijima, F., & Kashihara, N. (2009) · Hypertension Research · doi:10.1038/hr.2008.29 · Cited by 50
Litterio, M. C., Prieto, M. A. V., Adamo, A. M., Elesgaray, R., Oteiza, P. I., Galleano, M., & Fraga, C. G. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.02.004 · Cited by 50
“NO is degraded by superoxide anion in a near diffusion-limited rate reaction [6–8].”
Siasos, G., Tousoulis, D., Vlachopoulos, C., Antoniades, C. A., Stefanadi, E., Ioakeimidis, N., Zisimos, K., Siasou, Z., Papavassiliou, A. G., & Stefanadis, C. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.57 · Cited by 48
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Triggle, C. R., Ding, H., Marei, I., Anderson, T. J., & Hollenberg, M. D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0677 · Cited by 49
Sherratt, S. C. R., Dawoud, H., Bhatt, D. L., Maliñski, T., & Mason, R. P. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102337 · Cited by 52
Exposure to inhaled particulate matter impairs cardiac function in senescent mice
Tankersley, C. G., Champion, H. C., Takimoto, E., Gabrielson, K., Bedja, D., Misra, V., El‐Haddad, H., Rabold, R., & Mitzner, W. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00697.2007 · Cited by 49
“In the present study, the primary sources of NOS uncoupling may originate from substrate and/or cofactor limitations (16).”
BackgroundA Synergistic Vascular Effect of Airborne Particulate Matter and Nickel in a Mouse Model
Ying, Z., Xu, X., Chen, M., Liu, D., Zhong, M., Chen, L., Sun, Q., & Rajagopalan, S. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft136 · Cited by 49
“Oxidative stress is central in the pathophysiology of diverse cardiovascular diseases through disruption of vascular homeostasis (Forstermann and Munzel, 2006; Forstermann and Sessa, 2012; Rafikov et al., 2011).”
BackgroundTreps, L., Conradi, L., Harjes, U., & Carmeliet, P. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012492 · Cited by 52
“Thus, uncoupling of eNOS initiates and aggravates EC dysfunction and promotes atherosclerosis in the further disease course (Forstermann and Munzel, 2006; Thum et al., 2007).”
BackgroundLimbu, R., Cottrell, G., & McNeish, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192484 · Cited by 41
Wang, B., Chen, G., Urabe, G., Xie, R., Wang, Y., Shi, X., Guo, L., Gong, S., & Kent, K. C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.025 · Cited by 49
Resveratrol: A Multifunctional Compound Improving Endothelial Function
Li, H., & Förstermann, U. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6209-0 · Cited by 51
“All major risk factors for atherosclerosis such as hyperlipidemia, diabetes, hypertension and smoking are associated with endothelial dysfunction [10].”
BackgroundCircadian control of human cardiovascular function
Thosar, S. S., & Shea, S. A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.01.002 · Cited by 50
“In addition, mechanistic variables that affect VEF, namely endothelin-1 [60], and oxidative stress [61], both exhibited circadian rhythms with an increase across the morning hours and a peak around noon [1].”
BackgroundGenetic Elimination of eNOS Reduces Secondary Complications of Experimental Subarachnoid Hemorrhage
Sabri, M., Ai, J., Lass, E., D’Abbondanza, J. A., & Macdonald, R. L. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.49 · Cited by 48
Anemia in Heart Failure Patients
Alexandrakis, M. G., & Tsirakis, G. (2012) · ISRN Hematology · doi:10.5402/2012/246915 · Cited by 50
“Endothelial dysfunction associated with heart failure may alter endothelial NO synthase activity, hence further augmenting myocardial dysfunction due to increased oxidative stress [54].”
BackgroundZhang, M., Takimoto, E., Lee, D., Santos, C. X. C., Nakamura, T., Hsu, S., Jiang, A., Nagayama, T., Bedja, D., Yuan, Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.090977 · Cited by 46
Mazereeuw, G., Herrmann, N., Bennett, S. A. L., Swardfager, W., Xu, H., Valenzuela, N., Fai, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.010 · Cited by 47
The anti-inflammatory effect of Agaricus brasiliensis is partly due to its linoleic acid content
Saiki, R., Kawano, Y., Griensven, L. J. L. D. V., & Miyazaki, K. (2017) · Food & Function · doi:10.1039/c7fo01172e · Cited by 52
FGF23 impairs peripheral microvascular function in renal failure
Verkaik, M., Juni, R. P., van Loon, E. P. M., van Poelgeest, E. M., Kwekkeboom, R. F. J., Gam, Z., Richards, W. G., ter Wee, P. M., Hoenderop, J. G. J., Eringa, E. C., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00272.2018 · Cited by 48
Zhang, Z., Na, H., Gan, Q., Tao, Q., Alekseyev, Y., Hu, J., Yan, Z., Yang, J. B., Tian, H., Zhu, S., et al. (2021) · Aging Cell · doi:10.1111/acel.13501 · Cited by 45
Egea, G., Jiménez‐Altayó, F., & Campuzano, V. (2020) · Antioxidants · doi:10.3390/antiox9101013 · Cited by 52
“This process is known as eNOS uncoupling [65].”
BackgroundNoise, Air, and Heavy Metal Pollution as Risk Factors for Endothelial Dysfunction
Jiménez, M. T. B., Hahad, O., Kuntić, M., Daiber, A., & Münzel, T. F. (2023) · European Cardiology Review · doi:10.15420/ecr.2022.41 · Cited by 48
Activation of endothelial TRPM2 exacerbates blood–brain barrier degradation in ischemic stroke
Zong, P., Feng, J., Li, C. X., Jellison, E. R., Yue, Z., Miller, B. A., & Yue, L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad126 · Cited by 47
Holowatz, L. A., & Kenney, W. L. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.212100 · Cited by 47
“NOS3, which is normally dimerized, uncouples to a monomeric form without adequate substrate (Forstermann & Munzel, 2006), induced by upregulated arginase activity (Lim et al. 2007; Kim et al. 2009) or cofactor availability, and produces superoxide instead of NO (Moens & Kass, 2006).”
BackgroundSilva, M. A. B., Bruder-Nascimento, T. B., Cáu, S. B. D. A., Alves-Lopes, R., Mestriner, F., Fais, R. S., Touyz, R. M., & Tostes, R. C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00269 · Cited by 48
“…mice by decreasing oxidative stress and restoring NO/GC signaling Marcondes A. B. Silva 1, Thiago Bruder-Nascimento 1, Stefany B. A. Cau 1, Rheure A. M. Lopes 1, Fabiola L. A. C. Mestriner 1, Rafael S. Fais 1, Rhian M. Touyz 2 and Rita C. Tostes 1* 1Department of Pharmacology, Ribeirao Preto…”
BackgroundInfluentialLeiva, A., Fuenzalida, B., Barros, E., Sobrevia, B., Salsoso, R., Sáez, T., Villalobos-Labra, R., Silva, L., Chiarello, D. I., Toledo, F., et al. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666160222115158 · Cited by 50
Electrospun fibrinogen-PLA nanofibres for vascular tissue engineering
Gugutkov, D., Gustavsson, J., Cantini, M., Salmerón‐Sánchez, M., & Altankov, G. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2172 · Cited by 48
“Interestingly, although cells grew equally well on both type of nanofibres (Table 1), randomly orientated nanofibres provoked endothelial cells to produce significantly more NO, allowing the cells to better influence local vessel contractility and platelet activation (Förstermann and Münzel, 2006).”
BackgroundMelatonin mediates vasodilation through both direct and indirect activation of BKCa channels
Zhao, T., Zhang, H., Jin, C., Qiu, F., Wu, Y. H., & Shi, L. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0028 · Cited by 47
Oxidative burden in familial hypercholesterolemia
Mollazadeh, H., Carbone, F., Montecucco, F., Pirro, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26466 · Cited by 48
“According to experimental evidence, hypercholesterolemia was associated with reduced serum levels of BH4 and positively correlated with superoxide generation and OS (Prasanna &Purnima, 2011; Stroes et al., 1997).”
BackgroundEvidence of epigenetic alterations in thrombosis and coagulation: A systematic review
Patsouras, M., & Vlachoyiannopoulos, P. G. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102347 · Cited by 47
Sabbatinelli, J., Orlando, P., Galeazzi, R., Silvestri, S., Cirilli, I., Marcheggiani, F., Dludla, P. V., Giuliani, A., Bonfigli, A. R., Mazzanti, L., et al. (2020) · Nutrients · doi:10.3390/nu12041098 · Cited by 47
“The endothelium modulates the vascular tone mainly through nitric oxide (NO) synthesis by the endothelial isoform of NO synthase (eNOS) [9,10].”
BackgroundBala, C. G., Rusu, A., Ciobanu, D. M., Bucșa, C., & Román, G. (2021) · Antioxidants · doi:10.3390/antiox10040610 · Cited by 47
“NO is a key mediator in the regulation of vascular tone, platelet aggregation and vascular smooth cell proliferation, and thus, reduced NO levels are contributing factors to endothelial dysfunction in diabetes [35].”
BackgroundVassiliou, A. G., Zacharis, A., Keskinidou, C., Jahaj, E., Pratikaki, M. E., Gallos, P., Dimopoulou, I., Kotanidou, Α., & Orfanos, S. E. (2021) · Pharmaceuticals · doi:10.3390/ph14070695 · Cited by 47
“Experimental studies in various lung injury models have demonstrated that increased levels of eNOS-derived NO are associated with beneficial effects [6–14], while the high bioavailability of NO from inducible NO synthase (iNOS) may aggravate lung injury [15,16].”
BackgroundMasano, T., Kawashima, S., Toh, R., Satomi‐Kobayashi, S., Shinohara, M., Takaya, T., Sasaki, N., Takeda, M., Tawa, H., Yamashita, T., et al. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0072 · Cited by 47
On to the road to degradation: atherosclerosis and the proteasome
Herrmann, S. M., Lerman, L. O., & Lerman, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp333 · Cited by 47
“It has been postulated that superoxide production by the stimulation of NADPH oxidases would be the primary process to reduce BH4.”
BackgroundInfluentialComparison of the Antihypertensive Activity of Phenolic Acids
Yu, M., Kim, H., Heo, H., Kim, M.-J., Jeon, Y., Lee, H., & Lee, J. (2022) · Molecules · doi:10.3390/molecules27196185 · Cited by 46
“Nuclear factor-E2-related factor 2 (Nrf2), an antioxidant transcription factor important in CVD resistance [6], is highly sensitive to oxidative damage.”
BackgroundADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide
Sharma, M., Zhou, Z., Miura, H., Papapetropoulos, A., McCarthy, E. T., Sharma, R., Savin, V. J., & Lianos, E. A. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90369.2008 · Cited by 48
“NOS uncoupling may also result from insufficient levels of (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4) due to decreased synthesis or increased oxidation to BH2 (8, 30).”
BackgroundCulture of Human Endothelial Cells from Umbilical Veins
Siow, R. C. M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-367-7_18 · Cited by 46
Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions
Ferroni, P., Barbanti, P., Della‐Morte, D., Palmirotta, R., Jirillo, E., & Guadagni, F. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7260 · Cited by 50
“…in brain structures involved in headache (247, 385, 397) and by the implied role for NO in vascular tone regulation (201, 363), platelet activity (108), neuronal excitability and sensitization (290, 385), nociception (72, 215), allodynia (208), and migraine neurotrans-mission (247), has been…”
Wang, T., Wu, Z., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00668 · Cited by 46
“Nitric oxide plays a key role in the regulation of many physiological processes, such as vasodilation, inflammation, and neurodegeneration (Förstermann and Münzel, 2006; Brown, 2010).”
BackgroundHigh glutathionylation of placental endothelial nitric oxide synthase in preeclampsia
Guerby, P., Swiader, A., Augè, N., Parant, O., Vayssière, C., Uchida, K., Salvayre, R., & Nègre‐Salvayre, A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101126 · Cited by 49
“For instance, eNOS polymorphism (G894T and T-786C) [21,22], or eNOS uncoupling [17,23,24], have been associated with an increased risk of PE.”
BackgroundLázár, Z., Mészáros, M., & Bikov, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200522215047 · Cited by 47
Pathophysiology of the no-reflow phenomenon
Vrints, C. J. (2009) · Acute Cardiac Care · doi:10.1080/17482940902978061 · Cited by 46
Catechins and Proanthocyanidins Involvement in Metabolic Syndrome
Patanè, G. T., Putaggio, S., Tellone, E., Barreca, D., Ficarra, S., Maffei, C., Calderaro, A., & Laganà, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119228 · Cited by 45
Klein, J., Diaba‐Nuhoho, P., Giebe, S., Brunßen, C., & Morawietz, H. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02824-w · Cited by 45
“The oxidation of (6R)-5,6,7,8-tetrahydro-L-biopterin, a cofactor of the eNOS [27, 31], leads to uncoupling of the eNOS enzymes regularly acting as dimers [26, 57].”
BackgroundEffect of long-term piceatannol treatment on eNOS levels in cultured endothelial cells
Kinoshita, Y., Kawakami, S., Yanae, K., Sano, S., Uchida, H., Inagaki, H., & Ito, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.017 · Cited by 45
Luo, J., Wen, J., Zhou, H., Chen, X., & Zhang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087196 · Cited by 45
Endothelial Dysfunction and Coronary Artery Disease
Veerasamy, M., Bagnall, A. J., Neely, D., Allen, J., Sinclair, H., & Kunadian, V. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000047 · Cited by 45
“NO is generated from l-arginine constitutively by endothelial NO synthase (eNOS) and diffuses through to adjacent vascular smooth muscle cells to activate guanylate cyclase, which in turn leads to cyclic guanosine monophosphate-mediated vasodilatation.(10) Asymmetric dimethyl arginine (ADMA) is a potent competitive in…”
BackgroundEndothelial NOS (NOS3) impairs myocardial function in developing sepsis
van de Sandt, A. M., Windler, R., Gödecke, A., Ohlig, J., Zander, S., Reinartz, M. T., Graf, J., van Faassen, E. E., Rassaf, T., Schrader, J., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0330-8 · Cited by 47
“NOS3 itself can be a superoxide source, thereby causing endothelial dysfunction [14].”
BackgroundXu, C., Tang, F., Lü, M., Yang, J., Han, R., Mei, M., Hu, J., Zhou, M.-S., & Wang, H. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.009 · Cited by 45
Investigation of the role of nitric oxide driven angiogenesis by zinc oxide nanoflowers
Barui, A. K., Nethi, S. K., & Patra, C. R. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb03323g · Cited by 46
miRNA Involvement in Cerebral Ischemia-Reperfusion Injury
Neag, M. A., Mitre, A. O., Burlacu, C.-C., Inceu, A.-I., Mihu, C., Melincovici, C. S., Bichescu, M., & Buzoianu, A. D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.901360 · Cited by 44
Suppression of Diet-Induced Hypercholesterolemia by Scutellarin in Rats
Li, Q., Wu, J.-H., Guo, D.-J., Cheng, H.-L., Chen, S., & Chan, S. (2009) · Planta Medica · doi:10.1055/s-0029-1185539 · Cited by 44
Imamura, M., Waseda, Y., Marinova, G. V., Ishibashi, T., Obayashi, S., Sasaki, A., Nagai, A., & Azuma, H. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00406.2007 · Cited by 44
“However, it is still possible that free radical(s) rather than NO is produced as a result of “NOS uncoupling” (19) due to accumulation of endogenous NOS inhibitors as described below.”
BackgroundGrasemann, H., Dhaliwal, R., Ivanovska, J., Kantores, C., McNamara, P. J., Scott, J. A., Belik, J., & Jankov, R. P. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00328.2014 · Cited by 44
Haselden, W. D., Kedarasetti, R. T., & Drew, P. J. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008069 · Cited by 47
Feng, Y., Feng, Y., Gu, L., Liu, P., Cao, J., & Zhang, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.720632 · Cited by 44
“Suboptimal levels of BH4 due to the oxidation to BH2 via stimuli such as radiation exposure may lead to NOS uncoupling and the subsequent generation of highly oxidative radicals, including superoxide and peroxynitrite (77), which is the main mechanism of impaired vascular regulation (78).”
BackgroundOxidative stress and endothelial dysfunction
de Dios, S. T., Sobey, C. G., & Drummond, G. R. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0168-9_3 · Cited by 44
Steffen, Y., Vuillaume, G., Stolle, K., Röwer, K., Lietz, M., Schueller, J., Lebrun, S., & Wallerath, T. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.06.006 · Cited by 44
Drugs targeting nitric oxide synthase for migraine treatment
Barbanti, P., Egeo, G., Aurilia, C., Fofi, L., & Della‐Morte, D. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918953 · Cited by 44
“No research has developed selective eNOS inhibitors insofar as they are probably unsuitable for clinical application given this enzyme’s crucial involvement in the homeostatic regulation of numerous essential cardiovascular functions [14].”
BackgroundInhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction
Weerackody, R. P., Welsh, D., Wadsworth, R. M., & Peacock, A. J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00977.2008 · Cited by 44
“The uncoupling of eNOS leads to production of superoxide anion instead of NO and is increasingly appreciated as an important source of superoxide anion in the pathogenesis of cardiovascular disorders (15).”
BackgroundChen, S.-C., Liu, Y., Shyu, K., & Wang, D. L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.014 · Cited by 43
Nitric oxide synthase 3 contributes to ventilator-induced lung injury
Vaporidi, K., Francis, R. C. E., Bloch, K. D., & Zapol, W. M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00341.2009 · Cited by 43
Novel Therapies Targeting Vascular Endothelium
Tousoulis, D., Antoniades, C. A., Κούμαλλος, Ν., Marinou, K., Stefanadi, E., Latsios, G., & Stefanadis, C. (2006) · Endothelium · doi:10.1080/10623320601061714 · Cited by 42
Na, S., Kim, O. S., Ryoo, S., Kweon, T. D., Choi, Y. S., Shim, H. S., & Oh, Y. J. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01979 · Cited by 44
“organ, secreting vasoactive mediators under neurohumoral control.(3) It has been demonstrated that autonomic nerves and the endothelium work together to maintain vascular tone,(16)”
BackgroundInfluential
Metadata
- Authors
- Förstermann, U., & Münzel, T.
- Affiliations
- From the Departments of Pharmacology (U.F.) and Internal Medicine II (Cardiology) (T.M.), Johannes Gutenberg University Hospitals, Mainz, Germany.
- Venue
- Circulation
- Published
- 2006-04-04
- Volume
- 113
- Issue
- 13
- Pages
- 1708-1714
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2146190354
- Cited by
- 1,957
- References
- 67
- Citations by year
- 2026: 93 · 2025: 76 · 2024: 99 · 2023: 86 · 2022: 110 · 2021: 113 · 2020: 110 · 2019: 89 · 2018: 105 · 2017: 105 · 2016: 117 · 2015: 101 · 2014: 123 · 2013: 98 · 2012: 85
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial nitric oxide synthase, nitric oxide, tetrahydrobiopterin, eNOS uncoupling, NADPH oxidase, reactive oxygen species, superoxide, peroxynitrite, oxidative stress, cardiovascular risk factors, hypertension, hypercholesterolemia, diabetes mellitus, smoking, folic acid, vitamin C, L-arginine
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Nitric Oxide, Vascular Diseases, Reactive Oxygen Species, Oxidative Stress, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review